Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00

АШУҮИС — Судалгааны мэдээлэл (CRIS)

Permanent URI for this communityhttps://library.mnums.edu.mn/handle/123456789/5001

Browse

Search Results

Now showing 1 - 2 of 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Social capital and quality of life among caregivers of children with Autism Spectrum Disorder in Mongolia: a cross-sectional study
    (2025-09)
    Munkhsaikhan, Yanjinlkham
    ;
    ; ; ;
    Bold, Solongo
    BACKGROUND: Caregivers of children with Autism Spectrum Disorder (ASD) tend to experience a low quality of life (QoL) due to caregiving burdens. Supporting these caregivers, social capital is expected to improve their overall well-being. However, there is limited research on the relationship between social capital and QoL among caregivers of children with ASD in low- and middle-income countries. This study explored this association in the context of caregivers of children with ASD in Mongolia. METHODS: This study conducted a cross-sectional online survey using a structured questionnaire. Caregivers with a child diagnosed with ASD were recruited through institutions related to ASD in Mongolia. Social capital was assessed by the Looman Social Capital Scale. QoL was assessed using the 26-item World Health Organization Quality of Life instrument. The association between social capital and QoL was identified by using multiple linear regression analysis. RESULTS: Among 216 caregivers, the majority of them were mothers (87.1%), married (88.0%), and had higher education (84.3%). Over half of the children (59.7%) were between 0-4 years old, and 24.5% of the total children were girls. Having a better social capital score was positively associated with psychological well-being (B = 0.57, 95% CI [confidence interval] 0.29 to 0.85), social relationship (B = 0.58, 95% CI 0.17 to 0.99), and environmental support (B = 0.70, 95% CI 0.37 to 1.02) domains of QoL. No evidence was found on the association between social capital and the physical health domain of QoL. Among the four domains of QoL, environmental support had the lowest score (mean: 36.5, standard deviation: 13.9). CONCLUSIONS: This study is the first to explore the association between social capital and QoL among caregivers of children with ASD in low- and middle-income countries. Social capital was positively associated with three QoL domains, excluding the physical domain, with caregivers-mostly mothers-scoring the lowest in environmental support. Their social capital and QoL scores were lower than those in previous studies. To address these issues, resource-limited countries should implement community-level initiatives, such as peer support groups, alongside developing healthcare systems and social welfare programs tailored for caregivers and children with ASD.
    Scopus© Citations 1
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities
    (Elsevier BV, 2026-05)
    Vázquez, Daniel O
    ;
    Giavina-Bianchi, Pedro
    ;
    Josviack, Darío
    ;
    Kaplan, Allen P
    ;
    Martinez, Pablo A S
    The 2025 World Allergy Organization (WAO) Guidelines for the Classification, Diagnosis, and Treatment of Hereditary Angioedema (HAE) with Consideration of Worldwide Disparities provide a comprehensive, evidence-informed, and globally applicable framework for the care of this rare and potentially life-threatening disorder. HAE is a genetic disease characterized by recurrent episodes of subcutaneous and submucosal swelling, most commonly mediated by bradykinin, and is associated with substantial morbidity, impaired quality of life, and a lifelong risk of fatal laryngeal edema. The Guidelines were developed by an international panel of 40 experts from 22 countries, with representation from all world regions, reflecting the commitment of WAO to geographic diversity, inclusiveness, and global relevance. The development process for these guidelines followed a structured and transparent methodology that integrated systematic literature review, appraisal of real-world evidence, and application of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework adapted for rare diseases, complemented by a formal Delphi consensus process. This approach was specifically designed to address the limitations of conventional evidence hierarchies in rare disorders, while ensuring clinical applicability across heterogeneous healthcare systems and resource settings. A central element of the guidelines is an updated classification of HAE based on underlying pathophysiology and disease endotypes. The traditional distinction between HAE types 1 and 2 is unified under the term HAE with C1 inhibitor deficiency (HAE-C1-INH), reflecting shared biological mechanisms and management principles. The guidelines also recognize an expanding spectrum of HAE with normal C1 inhibitor (HAE-nC1-INH), including forms associated with pathogenic variants in F12, PLG, ANGPT1, KNG1, MYOF, HS3ST6, CPN1, and DAB2IP, as well as cases with currently unidentified genetic causes. The diagnostic strategy emphasizes early clinical recognition based on characteristic features, including recurrent angioedema without urticaria, abdominal or laryngeal involvement, early symptom onset, and family history. A simplified diagnostic algorithm is proposed, prioritizing the C1 inhibitor functional assay as the preferred initial test when performed in a reliable specialized laboratory. Alternative diagnostic pathways are outlined for settings with limited access to specialized testing, including pragmatic combinations of biochemical assays and selective use of genetic testing, particularly relevant for HAE-nC1-INH and family screening. Management recommendations address on-demand treatment of acute attacks, short-term prophylaxis, and individualized long-term prophylaxis. Universal access to on-demand therapy is emphasized for all patients with confirmed HAE, including those who are asymptomatic, given the unpredictable nature of attacks and lifelong risk. Long-term prophylaxis is addressed within a treat-to-target framework aimed at achieving complete disease control and sustained improvement in health-related quality of life, with regular reassessment and shared decision-making. Empowering patients and caregivers through structured education, access to appropriate medications, and integration with specialized referral centers is associated with earlier treatment, reduced healthcare utilization, and improved equity of care and reduced avoidable morbidity and mortality worldwide. The 2025 WAO Guidelines for Hereditary Angioedema establish an evidence-informed, patient-centered, and forward-looking framework for the classification, diagnosis, and management of HAE. By integrating advances in pathophysiology, diagnostics, and therapeutics with global expert consensus and real-world considerations, the guidelines aim to support consistent, equitable, and high-quality care for patients with HAE across regions and healthcare systems.
    Scopus© Citations 17